Orchid Pharma’s wholly owned subsidiary in India namely ‘Orchid Bio-Pharma’ has received approval to manufacture the product ‘7 ACA’ with a committed capacity of 1000 Metric Tonne Per Annum. This approval will help the Company in backward integration, reduce dependency on sourcing from China and aid in improving margins.
Orchid Pharma, established as an export-oriented unit (EOU), is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing.
